Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial

  • STATUS
    Recruiting
  • participants needed
    598
  • sponsor
    Eyecheck, Inc.
Updated on 22 September 2023

Summary

Protocol STRI12 - Study to Reinforce Immunity (STRI) - A Phase 2 Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of STRI Formula in Non-Hospitalized Participants with COVID-19 (the Study)

Description

The Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial is a randomized, double-blind, placebo-controlled clinical trial protocol assessing the safety and efficacy of STRI Formula in non-hospitalized participants with COVID-19. STRI Formula is a combination of food-based substances designed specifically to combat SARS-CoV-2, the coronavirus that causes COVID-19.

The primary objective of the Study is to assess the efficacy of STRI Formula in reduction of time from treatment initiation to initial meaningful clinical improvement in COVID-19 symptoms. Additional secondary objectives are as follows:

  1. To assess the safety of STRI Formula
  2. To assess the efficacy of STRI Formula in reduction of time to COVID-19 sustained symptom improvement
  3. To assess the efficacy of STRI Formula in reduction of time to COVID-19 initial symptom resolution
  4. To assess the efficacy of STRI Formula in reduction of time to COVID-19 sustained symptom resolution
  5. To assess the efficacy of STRI Formula in reduction in need for hospitalization
  6. To assess the efficacy of STRI Formula in reduction in rates of fever
  7. To assess the efficacy of STRI Formula in reduction in rates of hypoxia

Details
Condition Covid19
Treatment Placebo, STRI Formula
Clinical Study IdentifierNCT05046561
SponsorEyecheck, Inc.
Last Modified on22 September 2023

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note